WCG: 2020 in Review: Celebrating the Successes of the Clinical Research Community After A Difficult Year

Datum: 2 December 2020

Tijd: 2:00 pm 3:00 p.m. ET

Locatie: Webinar

This past year, impacted so greatly by the COVID-19 pandemic, has been a difficult year for the clinical research community. But we’ve also seen the pressures of the past year translated into remarkable achievements in how we design and conduct clinical trials. In this webinar, we’ll review what happened in 2020, and look at some of the metrics. Several of WCG’s clinical research experts will also talk about the changes they saw across different parts of the clinical research ecosystem in 2020, how the stressors brought about positive changes, and why they are optimistic about the future as we move into 2021.

Continue Reading

WCG CenterWatch: Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

Datum: 3 December 2020

Tijd: 10:00 a.m. - 4:30 p.m. EST

Locatie: Online

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges is an interactive virtual workshop that will give you the tools you need to ensure your clinical trials’ electronic records are trustworthy and reliable across their entire data lifecycle, from initial data creation through long-term archives.

Continue Reading

WCG CenterWatch: Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

Datum: 1 December 2020

Tijd: 10:00 a.m. - 4:30 p.m. EST

Locatie: Online

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges is an interactive virtual workshop that will give you the tools you need to ensure your clinical trials’ electronic records are trustworthy and reliable across their entire data lifecycle, from initial data creation through long-term archives.

Continue Reading

WCG Centerwatch: FDAnews/CenterWatch Virtual Conference – Part I: The Impact of COVID-19: Complying with Data Integrity Guidelines in the Midst of a Pandemic

Datum: 4 August 2020

Tijd: 1.30 p.m. - 5.00 p.m. EDT

In the first portion, we’ll cover how the FDA’s new guidance impacts data integrity, ways medical product companies are conducting clinical trials during the current pandemic, and how data integrity might change permanently as a result of COVID-19 changes. We’ll also discuss techniques for managing inspections, audits, and supply chain concerns.

Continue Reading